Effects and Safety of Metronidazole in Patients With Gastrectomy

Summary

Recent study showed that SIBO is common among postgastrectomy patients and It appears to be associated with postprandial intestinal symptoms and might aggravate late hypoglycemia. SIBO could be a new therapeutic target for managing intestinal symptoms in postgastrectomy patients.The purpose of this study is to determine whether antiboitic (metronidazole) is effective in patients with postgasrectomy syndrome

Timeline

Start

2011-05

Primary completion

2014-05

Completion

2014-05

Drugs

Indications